pharma · Not applicable, Healthy Volunteers · advanced/metastatic non-squamous non-small cell lung cancer (NSCLC)
mAbxience
Mabxience Research SL
mAbxience patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- madrid, ES
- Founded
- 2009
- Employees
- 1,194
- Programs
- 5
- Drugs
- 10
- Patents
- 0
mAbxience patents
0 pharmaceutical patents indexed for mAbxience. 0 expire within 24 months.
mAbxience has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does mAbxience have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do mAbxience patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.